APR is a systemic phenomenon that accompanies inflammation, in which IL-6, interleukin(IL)-1β (IL-1β), and tumour necrosis factor-α (TNF-α) synergistically cooperate to mitigate potential infection and further tissue injury [122,123,124]. Here, IL6 is linked to infection.